159 related articles for article (PubMed ID: 20971975)
1. Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.
Millar JS; Ikewaki K; Bloedon LT; Wolfe ML; Szapary PO; Rader DJ
J Lipid Res; 2011 Jan; 52(1):136-42. PubMed ID: 20971975
[TBL] [Abstract][Full Text] [Related]
2. Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.
Millar JS; Duffy D; Gadi R; Bloedon LT; Dunbar RL; Wolfe ML; Movva R; Shah A; Fuki IV; McCoy M; Harris CJ; Wang MD; Howey DC; Rader DJ
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):140-6. PubMed ID: 18988892
[TBL] [Abstract][Full Text] [Related]
3. Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Ng TW; Chan DC; Barrett PH; Watts GF
Clin Sci (Lond); 2009 Oct; 118(1):79-85. PubMed ID: 19456294
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein apolipoprotein A-I kinetics in obesity.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Obes Res; 2005 Jun; 13(6):1008-16. PubMed ID: 15976143
[TBL] [Abstract][Full Text] [Related]
5. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
[TBL] [Abstract][Full Text] [Related]
6. Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome.
Richard C; Couture P; Desroches S; Lichtenstein AH; Lamarche B
Nutr J; 2013 Jun; 12(1):76. PubMed ID: 24499022
[TBL] [Abstract][Full Text] [Related]
7. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
Pietzsch J; Julius U; Nitzsche S; Hanefeld M
Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
[TBL] [Abstract][Full Text] [Related]
8. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Brinton EA; Eisenberg S; Breslow JL
Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
[TBL] [Abstract][Full Text] [Related]
9. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
[TBL] [Abstract][Full Text] [Related]
10. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.
Vélez-Carrasco W; Lichtenstein AH; Welty FK; Li Z; Lamon-Fava S; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):918-24. PubMed ID: 10195918
[TBL] [Abstract][Full Text] [Related]
11. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II.
De Oliveira E Silva ER; Foster D; McGee Harper M; Seidman CE; Smith JD; Breslow JL; Brinton EA
Circulation; 2000 Nov; 102(19):2347-52. PubMed ID: 11067787
[TBL] [Abstract][Full Text] [Related]
12. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
13. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
15. Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys.
Huggins KW; Colvin PL; Burleson ER; Kelley K; Sawyer JK; Barrett PH; Rudel LL; Parks JS
J Lipid Res; 2001 Sep; 42(9):1457-66. PubMed ID: 11518766
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
Ji J; Watts GF; Johnson AG; Chan DC; Ooi EM; Rye KA; Serone AP; Barrett PH
J Clin Endocrinol Metab; 2006 Mar; 91(3):973-9. PubMed ID: 16368749
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
Alemzadeh R; Kichler J
Metab Syndr Relat Disord; 2018 Feb; 16(1):40-45. PubMed ID: 29154726
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.
Carreón-Torres E; Rendón-Sauer K; Monter-Garrido M; Toledo-Ibelles P; Gamboa R; Menjivar M; López-Marure R; Luc G; Fievet C; Cruz D; Vargas-Alarcón G; Pérez-Méndez O
Clin Chim Acta; 2009 Mar; 401(1-2):37-41. PubMed ID: 19036342
[TBL] [Abstract][Full Text] [Related]
19. Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
Lamon-Fava S; Diffenderfer MR; Barrett PH; Buchsbaum A; Nyaku M; Horvath KV; Asztalos BF; Otokozawa S; Ai M; Matthan NR; Lichtenstein AH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1672-8. PubMed ID: 18566298
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.
Vergès B; Florentin E; Baillot-Rudoni S; Petit JM; Brindisi MC; Pais de Barros JP; Lagrost L; Gambert P; Duvillard L
J Lipid Res; 2009 Jun; 50(6):1209-15. PubMed ID: 19168444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
